Tetsuya Eto

8.3k total citations
263 papers, 3.9k citations indexed

About

Tetsuya Eto is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Tetsuya Eto has authored 263 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Hematology, 75 papers in Immunology and 63 papers in Oncology. Recurrent topics in Tetsuya Eto's work include Hematopoietic Stem Cell Transplantation (137 papers), Acute Myeloid Leukemia Research (67 papers) and Acute Lymphoblastic Leukemia research (54 papers). Tetsuya Eto is often cited by papers focused on Hematopoietic Stem Cell Transplantation (137 papers), Acute Myeloid Leukemia Research (67 papers) and Acute Lymphoblastic Leukemia research (54 papers). Tetsuya Eto collaborates with scholars based in Japan, United States and Australia. Tetsuya Eto's co-authors include Takahiro Fukuda, Yoshiko Atsuta, Toshihiro Miyamoto, Koichi Akashi, Shuichi Taniguchi, Koji Nagafuji, Takanori Teshima, Koichi Miyamura, Takehiko Mori and Koji Kato and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Tetsuya Eto

242 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuya Eto Japan	34	1.9k	1.1k	886	645	566	263	3.9k
Zaher K. Otrock Lebanon	26	1.1k 0.6×	768 0.7×	553 0.6×	376 0.6×	770 1.4×	116	3.0k
Yasuhito Nannya Japan	33	1.3k 0.7×	479 0.4×	585 0.7×	564 0.9×	1.4k 2.4×	219	3.9k
Satoshi Hashino Japan	26	874 0.5×	638 0.6×	477 0.5×	174 0.3×	409 0.7×	153	2.3k
A Hiraoka Japan	26	1.5k 0.8×	549 0.5×	681 0.8×	219 0.3×	1.0k 1.9×	88	2.8k
Peter Bardy Australia	28	1.0k 0.6×	957 0.8×	555 0.6×	245 0.4×	387 0.7×	93	2.5k
Je‐Jung Lee South Korea	36	1.4k 0.7×	1.9k 1.7×	1.7k 1.9×	479 0.7×	1.3k 2.2×	330	4.5k
E Platzer United States	26	1.2k 0.6×	2.0k 1.8×	1.6k 1.8×	287 0.4×	817 1.4×	38	4.5k
B Speck Switzerland	36	4.8k 2.6×	2.3k 2.0×	1.5k 1.7×	1.1k 1.7×	456 0.8×	200	6.4k
William R. Drobyski United States	44	4.1k 2.2×	3.1k 2.7×	2.2k 2.5×	579 0.9×	767 1.4×	147	7.2k
Günther Gastl Austria	38	959 0.5×	1.2k 1.1×	1.3k 1.4×	650 1.0×	1.2k 2.1×	137	4.3k

Countries citing papers authored by Tetsuya Eto

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Eto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Eto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Eto more than expected).

Fields of papers citing papers by Tetsuya Eto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Eto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Eto. The network helps show where Tetsuya Eto may publish in the future.

Co-authorship network of co-authors of Tetsuya Eto

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Eto. A scholar is included among the top collaborators of Tetsuya Eto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Eto. Tetsuya Eto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harada, Naonori, Junya Kanda, Hiromi Hayashi, et al.. (2025). Evaluation of the Prognostic Impact of Infused CD34 Positive Cell Dose in Haplo-Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide Using a Restricted Cubic Spline Curve. Transplantation and Cellular Therapy. 31(2). S262–S262. 1 indexed citations

Arai, Yasuyuki, Tadakazu Kondo, Shigeki Hirabayashi, et al.. (2025). HLA‐matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML. eJHaem. 6(1). e21088–e21088.

Fukunaga, Keiko, Kazuhiro Ikegame, Hirohisa Nakamae, et al.. (2024). HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis. International Journal of Hematology. 119(2). 173–182.

Arai, Yasuyuki, Tadakazu Kondo, Shohei Mizuno, et al.. (2024). Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia. Cytotherapy. 26(6). 592–598. 2 indexed citations

Kuwatsuka, Yachiyo, Rika Kasajima, Rui Yamaguchi, et al.. (2024). Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation. Transplantation and Cellular Therapy. 30(4). 444.e1–444.e11. 1 indexed citations

Harada, Kaito, Junya Kanda, Masahiro Hirayama, et al.. (2024). Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease. Transplantation and Cellular Therapy. 31(2). 103.e1–103.e13. 2 indexed citations

Itonaga, Hidehiro, Yasushi Miyazaki, Kazunari Aoki, et al.. (2023). Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database. Annals of Hematology. 102(5). 1215–1227. 1 indexed citations

Okinaka, Keiji, Yoshitaka Inoue, Naoyuki Uchida, et al.. (2023). Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study. Journal of Infection and Chemotherapy. 29(7). 726–730. 3 indexed citations

Sugita, Junichi, Jun Ishikawa, Tetsuya Eto, et al.. (2023). Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplantation. 59(3). 344–349.

10.

Sugio, Takeshi, Koji Kato, Shuro Yoshida, et al.. (2022). Short-term methotrexate plus cyclosporine for graft-versus-host disease prophylaxis after single-unit cord blood transplantation following reduced-intensity conditioning. 11(1). 64–71.

11.

Konuma, Takaaki, Junya Kanda, Yachiyo Kuwatsuka, et al.. (2021). Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type. Clinical Cancer Research. 27(17). 4825–4835. 15 indexed citations

12.

Shimomura, Yoshimitsu, Masahiko Hara, Takaaki Konuma, et al.. (2021). Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients. Bone Marrow Transplantation. 56(10). 2510–2517. 9 indexed citations

13.

Inoue, Yoshitaka, Keiji Okinaka, Shigeo Fuji, et al.. (2021). Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study. Bone Marrow Transplantation. 56(9). 2125–2136. 5 indexed citations

14.

Kurosawa, Shuhei, Shohei Mizuno, Yasuyuki Arai, et al.. (2021). Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis. Blood Cancer Journal. 11(9). 159–159. 3 indexed citations

15.

Miyamoto, Toshihiro, Tetsuya Eto, Naoyuki Uchida, et al.. (2021). Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood & Marrow Transplant Group Studies ALL MRD 2002 and 2008. International Journal of Hematology. 113(6). 815–822. 2 indexed citations

16.

Yamamoto, Shohei, Daisuke Tomizawa, Kazuko Kudo, et al.. (2020). Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan. Pediatric Blood & Cancer. 67(5). e28181–e28181. 5 indexed citations

17.

Sugita, Junichi, Tomohiko Kamimura, Takayuki Ishikawa, et al.. (2020). Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation. Bone Marrow Transplantation. 56(3). 596–604. 33 indexed citations

18.

Nagafuji, Koji, Toshihiro Miyamoto, Tetsuya Eto, et al.. (2019). Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph‐negative acute lymphoblastic leukemia. European Journal Of Haematology. 103(3). 164–171. 8 indexed citations

19.

Kawamoto, Keisuke, Hiroaki Miyoshi, Eriko Yanagida, et al.. (2017). Comparison of clinicopathological characteristics between T‐cell prolymphocytic leukemia and peripheral T‐cell lymphoma, not otherwise specified. European Journal Of Haematology. 98(5). 459–466. 9 indexed citations

20.

Morishima, Yasuo, Koichi Kashiwase, Keitaro Matsuo, et al.. (2014). Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood. 125(7). 1189–1197. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact